|
08.07.25 - 23:06
|
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025 (Business Wire)
|
|
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2025 results on Tuesday, August 5, 2025.
The Company will host a conference call on Tuesday, August 5, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com.
A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. The replay will remain available until Monday, September 29, 2025.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical, life science, and adv...
|
|
|
06.05.25 - 15:46
|
Novanta (NOVT) Q1 Earnings Beat Estimates (Zacks)
|
|
Novanta (NOVT) delivered earnings and revenue surprises of 8.82% and 0.28%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
06.05.25 - 13:06
|
Novanta Announces Financial Results for the First Quarter 2025 (Business Wire)
|
|
First Quarter 2025 GAAP Revenue increased 1% to $233 million
First Quarter 2025 GAAP Diluted Earnings Per Share of $0.59 and Adjusted EPS of $0.74
First Quarter 2025 GAAP Net Income increased 45% to $21 million
First Quarter 2025 Adjusted EBITDA increased 1% to $50 million
First Quarter 2025 Operating Cash Flow of $32 million
Company reiterates Full Year 2025 Adjusted EBITDA guidance
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025.
Financial Highlights
Three Months Ended
(In millions, except per share amounts)
March 28,
March 29,
2025
2024
GAAP
Revenue
$
233.4
$
230.9
Operating Income
$
32.4
$
25.6
Net Income
$
21.2
$
14.7
Diluted EPS
$
0.59
$
0.41
Non-GAAP*
Adjusted Operating Income
$
39.1
$
40.1
Adjusted Diluted EPS
$...
|
|
08.04.25 - 23:03
|
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025 (Business Wire)
|
|
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2025 results on Tuesday, May 6, 2025.
The Company will host a conference call on Tuesday, May 6, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com.
A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. The replay will remain available until Monday, June 30, 2025.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical, life science, and advance...
|
|
|
|
25.02.25 - 16:15
|
Novanta (NOVT) Q4 Earnings Beat Estimates (Zacks)
|
|
Novanta (NOVT) delivered earnings and revenue surprises of 7.04% and 0.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
|
|
25.02.25 - 13:03
|
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024 (Business Wire)
|
|
Fourth Quarter 2024 GAAP Revenue increased 13% to $238 million, including $2 million unfavorable FX impact
Fourth Quarter 2024 GAAP Diluted EPS of $0.46 and Adjusted EPS of $0.76
Full Year 2024 GAAP Revenue increased 8% to $949 million
Full Year 2024 GAAP Diluted EPS of $1.77, and Adjusted EPS of $3.08
Full Year 2024 Adjusted EBITDA increased 7% to $210 million
Full Year 2024 Operating Cash Flow increased 32% to $159 million
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024.
Financial Highlights
Three Months Ended
December 31,
Year Ended
December 31,
(In millions, except per share amounts)
2024
2023
2024
2023
GAAP
Revenue
$
238.1
$
211.6
$
949.2
$
881.7
Operating Income
$
26.7
$
21.7
$
110.6
?...
|
|
|
28.01.25 - 23:03
|
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025 (Business Wire)
|
|
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025.
The Company will host a conference call on Tuesday, February 25, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com.
A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. The replay will remain available until Monday, April 21, 2025.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medica...
|
|
|
|
|
|
|
|
05.11.24 - 15:48
|
Novanta (NOVT) Q3 Earnings Miss Estimates (Zacks)
|
|
Novanta (NOVT) delivered earnings and revenue surprises of -1.16% and 1.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|